Fayon Adrien, Menu Patrick, El Omar Reine
Université de Lorraine, CNRS, IMoPA, F-54000 Nancy, France.
Université de Lorraine, Faculté de Pharmacie, Nancy, F-54000, France.
NPJ Regen Med. 2021 Aug 12;6(1):46. doi: 10.1038/s41536-021-00155-x.
Due to the lack of efficacy of synthetic vascular substitutes in the replacement of small-caliber arteries, vascular tissue engineering (VTE) has emerged as a promising solution to produce viable small-caliber tissue-engineered vascular grafts (TEVG). Previous studies have shown the importance of a cellular intimal layer at the luminal surface of TEVG to prevent thrombotic events. However, the cellularization of a TEVG seems to be a critical approach to consider in the development of a TEVG. To date, no standard cellularization method or cell type has been established to create the ideal TEVG by promoting its long-term patency and function. In this review, advances in VTE are described and discussed with a particular focus on the construction approaches of cellularized small-caliber TEVGs, the cell types used, as well as their preclinical and clinical applications.
由于合成血管替代物在替代小口径动脉方面缺乏疗效,血管组织工程(VTE)已成为一种有前景的解决方案,用于生产可行的小口径组织工程血管移植物(TEVG)。先前的研究表明,TEVG管腔表面的细胞内膜层对于预防血栓形成事件很重要。然而,TEVG的细胞化似乎是TEVG开发中需要考虑的关键方法。迄今为止,尚未建立标准的细胞化方法或细胞类型来通过促进其长期通畅性和功能来创建理想的TEVG。在这篇综述中,将描述和讨论VTE的进展,特别关注细胞化小口径TEVG的构建方法、所用的细胞类型及其临床前和临床应用。